YOLFTbeta
Hanmi Pharm Co Ltd

Hanmi Pharm Co Ltd

128940 · KO · Healthcare / Drug Manufacturers - Specialty & Generic

465,500.00KRW-7500.00 (-1.59%)

Price History

Full chart

Market Stats

Previous Close473,000.00
Open456,000.00
Day Range454,500.00 – 493,000.00
52-Week Range302,000.00 – 644,642.99
Volume138.20K
Market Cap6.31T
P/E (TTM)0.00
Forward P/E0.00
Dividend Yield0.40%
Beta0.56
50-Day Avg446,160.00
200-Day Avg470,200.00

About

Hanmi Pharm. Co., Ltd., a biopharmaceutical company, engages in the manufacture and sale of pharmaceutical products in South Korea, China, Japan, the United States, and internationally. It focuses on research areas with high unmet medical needs, including obesity, metabolism, oncology, and rare diseases. The company's products include Gugutams, a urological combination therapy combining two active ingredients: tamsulosin, a treatment for Obstructive Prostatic Growth (OPG), and tadalafil, a treatment for erectile dysfunction (ED). The company has a research collaboration with MEDIC Life Sciences Inc. to identify cancer biomarkers. The company was founded in 1973 and is based in Hwaseong-si, South Korea.

Company Details

  • SectorHealthcare
  • IndustryDrug Manufacturers - Specialty & Generic
  • CEOMr. Jae-Hyun Park
  • Employees2.40K
  • Headquarters214 Muha-ro, Hwaseong-si, South Korea, 18536, Korea
  • Websitehttps://www.hanmipharm.com

Leadership

  • Mr. Jae-Hyun ParkCEO & Director · b. 1968
  • Mr. Lim Chong-YoonPresident of Business Development & Executive Director · b. 1972
  • Mr. Jong-Hoon LimCSR Executive Director · b. 1961
  • Byung-hwa ShimChief Finance Officer
  • Yang-Hwan ChoiGroup Head of IR
  • Mr. Jong-Soo Woo Ph.D.Executive Director · b. 1967
  • Mr. Jong-Hoon LimExecutive Director & Management Planning /CIO · b. 1977
  • Chang-Ju ChoiVice President of Information Management Team

Financials

Income Statement

Currency: KRW2010-12-312011-12-312012-12-312013-12-312014-12-312015-12-312016-12-312017-12-312018-12-312019-12-312020-12-312021-12-312022-12-312023-12-312024-12-312025-12-31
Total Revenue337.38B606.19B674.01B730.13B761.28B1.32T882.72B916.59B1.02T1.11T1.08T1.20T1.33T1.49T1.50T1.55T
Growth (%)-+79.68%+11.19%+8.33%+4.27%+73.07%-33.00%+3.84%+10.84%+9.62%-3.39%+11.84%+10.67%+11.97%+0.31%+3.48%
Cost of Revenue126.26B241.61B250.59B290.31B316.75B398.71B421.87B398.18B475.05B481.17B494.94B570.43B612.99B661.64B678.46B663.12B
Gross Profit---416.12B422.12B918.82B460.86B518.40B540.92B632.48B580.92B632.75B718.55B829.25B817.04B884.41B
Gross Margin---56.99%55.45%69.74%52.21%56.56%53.24%56.79%54.00%52.59%53.96%55.62%54.63%57.15%
Operating Expense---354.22B387.67B707.02B434.08B436.24B457.34B528.60B531.94B507.34B560.46B604.36B600.85B626.61B
Operating Income-21.19B48.14B61.90B34.45B211.80B26.77B82.16B83.57B103.88B48.98B125.42B158.09B224.88B216.19B257.80B
Operating Margin-3.50%7.14%8.48%4.53%16.08%3.03%8.96%8.23%9.33%4.55%10.42%11.87%15.08%14.46%16.66%
EBITDA-------106.01B116.96B163.68B108.34B209.36B240.50B320.93B292.96B329.27B
EBITDA Margin-------11.57%11.51%14.70%10.07%17.40%18.06%21.53%19.59%21.28%
Net Income-1.29B22.64B43.93B35.51B154.44B23.33B60.43B24.89B52.11B11.96B67.03B82.79B146.23B121.32B169.55B
Net Income Margin-0.21%3.36%6.02%4.66%11.72%2.64%6.59%2.45%4.68%1.11%5.57%6.22%9.81%8.11%10.96%
R&D32.08B84.02B91.04B115.59B152.52B167.99B142.89B151.29B165.91B194.29B212.39B146.03B154.32B181.77B178.89B195.83B
R&D as % of Total Revenue9.51%13.86%13.51%15.83%20.03%12.75%16.19%16.51%16.33%17.45%19.74%12.14%11.59%12.19%11.96%12.65%
Interest Expense0000000019.41B25.00B24.87B16.58B22.65B28.51B24.37B16.99B
Interest Expense % of Total Revenue0.00%0.00%0.00%0.00%0.00%0.00%0.00%0.00%1.91%2.24%2.31%1.38%1.70%1.91%1.63%1.10%

Balance Sheet

Currency: KRW2010-12-312011-12-312012-12-312013-12-312014-12-312015-12-312016-12-312017-12-312018-12-312019-12-312020-12-312021-12-312022-12-312023-12-312024-12-312025-12-31
Total Assets747.72B787.75B835.59B880.87B1.03T1.72T1.60T1.66T1.69T1.91T1.88T1.94T1.92T1.90T2.02T2.14T
Total Liabilities422.34B409.53B426.25B417.95B444.09B977.78B862.45B868.51B901.95B1.09T1.05T1.01T915.36B798.46B780.09B714.74B
Total Equity292.01B336.28B362.42B409.39B527.46B674.95B659.46B711.71B703.23B723.80B729.99B802.91B871.87B955.44B1.08T1.25T
Cash12.14B21.63B55.16B69.30B52.47B138.33B130.37B47.27B67.34B106.11B146.16B209.22B147.33B54.98B192.28B108.27B
Net Debt-------427.49B562.49B735.67B642.63B481.42B519.46B508.50B295.42B316.59B

Cash Flow

Currency: KRW2010-12-312011-12-312012-12-312013-12-312014-12-312015-12-312016-12-312017-12-312018-12-312019-12-312020-12-312021-12-312022-12-312023-12-312024-12-312025-12-31
Operating Cash Flow18.94B61.30B63.27B85.99B-32.82B101.71B412.97B-62.91B25.98B12.45B151.53B201.92B162.27B216.54B193.49B173.07B
Investing Cash Flow----38.33B-69.20B-114.37B-355.15B-152.89B-145.83B-172.94B-45.17B-43.39B-181.41B---
Financing Cash Flow7.68B-12.20B-32.25B85.12B94.54B-62.94B137.75B140.44B198.60B-65.19B-113.33B-36.87B---
Capital Expenditure20.46B19.56B13.87B26.57B69.18B121.07B224.09B247.05B182.27B166.13B41.82B19.95B30.38B43.74B62.55B76.55B
Free Cash Flow--------325.24B-185.25B-165.93B93.70B167.50B112.68B172.80B130.93B96.53B
Dividends Paid-155.40M-20.42B20.42B20.42B20.42B8.96B8.96B5.66B8.14B5.88B5.99B18.00B12.56B30.86B
FCF to OCF-------517.03%-712.98%-1333.11%61.83%82.95%69.44%79.80%67.67%55.77%
Dividend Paid to FCF--------2.75%-4.83%-3.41%8.69%3.51%5.32%10.41%9.59%31.97%

Earnings

Report DateAug 1, 2011May 30, 2012Aug 29, 2012Nov 28, 2012Mar 28, 2013May 29, 2013Aug 28, 2013Nov 27, 2013Feb 26, 2014May 28, 2014Sep 3, 2014Nov 14, 2014Feb 5, 2015Apr 30, 2015Aug 17, 2015Oct 27, 2015Mar 11, 2016Apr 28, 2016Aug 16, 2016Nov 14, 2016Mar 2, 2017Apr 27, 2017Aug 11, 2017Nov 14, 2017Jan 29, 2018May 15, 2018Jul 31, 2018Nov 14, 2018Jan 29, 2019May 14, 2019Aug 14, 2019Nov 14, 2019Feb 6, 2020May 15, 2020Aug 14, 2020Nov 16, 2020Feb 4, 2021May 17, 2021Aug 17, 2021Nov 15, 2021Mar 16, 2022May 16, 2022Aug 16, 2022Nov 14, 2022Feb 8, 2023Apr 26, 2023Jul 28, 2023Nov 1, 2023Feb 2, 2024Apr 30, 2024Jul 30, 2024Oct 31, 2024Feb 4, 2025Apr 29, 2025Jul 30, 2025Oct 30, 2025Feb 6, 2026Apr 28, 2026Jul 28, 2026Oct 29, 2026
EPS Estimate87.93---919.86------644.53--370.91-899.03-2313.781722.541732.12944.281398.641542.281117.771465.151158.591101.75393.721932.42842.91624.78599.321518.13691.871156.80778.821489.851255.411412.302516.941729.06860.561567.791759.652539.051734.402788.772560.073611.062457.663039.762006.324276.4535.70-----
EPS Actual41.34-225.13404.28831.72718.381069.17689.941205.59817.871162.77589.5688.121050.001008.78616.58-2129.1812289.423036.871570.25374.26-3315.091634.95976.771616.63719.91603.821141.87903.07-656.48999.931439.21505.401213.96592.18587.57-2422.322251.061497.35558.801840.361295.661566.671450.401997.311564.243467.001124.004397.002764.484337.003176.002445.00-390.733360.003052.353164.653785.183585.706565.50-
Surprise-52.99%----21.90%-------86.33%--66.23%-1266.96%--32.13%-78.27%-291.39%73.14%-30.16%4.82%-35.59%-58.79%-1.44%-18.03%-266.74%-48.26%70.74%-19.11%102.56%-60.99%-15.08%-309.40%189.03%0.50%-55.49%30.31%-48.52%-9.39%68.54%27.40%-11.11%36.55%-35.19%57.67%7.98%20.10%29.23%-19.57%-119.48%-21.43%8450.00%-----
Timing----After-hours------Pre-market-Pre-marketAfter-hoursPre-marketPre-marketPre-marketAfter-hoursAfter-hoursAfter-hoursPre-marketPre-marketPre-marketPre-marketPre-marketPre-marketPre-market-Pre-marketPre-marketPre-marketAfter-hoursPre-marketPre-marketPre-market-Pre-marketPre-marketPre-marketPre-marketAfter-hoursPre-marketPre-marketPre-marketPre-marketPre-marketPre-marketPre-marketPre-marketPre-marketPre-marketPre-marketPre-marketPre-marketPre-market-Pre-marketPre-marketPre-market

Key Statistics & Ratios

Market Cap6.31T
Enterprise Value6.61T
Trailing P/E0.00
Forward P/E0.00
PEG Ratio0.00
Price / Sales3.81
Price / Book4.70
Revenue (TTM)1.66T
Gross Profit (TTM)986.57B
EBITDA375.90B
Profit Margin13.11%
Operating Margin26.43%
Return on Equity16.36%
Return on Assets8.04%
Shares Outstanding12.69M
Shares Float6.34M
Beta0.56
Dividend Yield0.40%
Dividend Rate2,000.00
Payout Ratio11.70%

Dividends

20261×
2000.00Mar 30, 2026
20242×
1000.00Dec 27, 2024250.00Jun 27, 2024
20231×
500.00Dec 27, 2023
20221×
490.20Dec 28, 2022
20211×
480.58Dec 29, 2021
20201×
471.16Dec 29, 2020
20191×
452.87Dec 27, 2019
20181×
452.87Dec 27, 2018
20171×
443.99Dec 27, 2017
20151×
1595.31Dec 29, 2015

Stock Splits

  • Dec 27, 20231.02:1
  • Dec 28, 20221.02:1
  • Dec 29, 20211.02:1
  • Dec 29, 20201.02:1
  • Dec 27, 20191.02:1
  • Dec 27, 20181.02:1
  • Dec 27, 20171.02:1
  • Feb 15, 20171.07:1
  • Dec 29, 20151.02:1
  • Dec 29, 20141.05:1
  • Feb 10, 20141.05:1
  • Dec 27, 20121.05:1
  • Dec 28, 20111.05:1
  • Dec 29, 20101.05:1